About Sirigen
Sirigen is a company based in San Diego (United States) founded in 2003 was acquired by Becton Dickinson in August 2012.. Sirigen has raised $12.05 million across 3 funding rounds from investors including BD, Seraphim and YFM Equity Partners. Sirigen operates in a competitive market with competitors including NuProbe, Nanosphere, ATDBio, Marker Gene Technologies and DestiNA Genomics, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Sirigen Inc
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$12.05 M (USD)
in 3 rounds
-
Latest Funding Round
$6.11 M (USD), Series B
Oct 01, 2010
-
Investors
BD
& 5 more
-
Employee Count
Employee Count
-
Acquired by
Becton Dickinson
(Aug 27, 2012)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sirigen
Sirigen has successfully raised a total of $12.05M across 3 strategic funding rounds. The most recent funding activity was a Series B round of $6.11 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series B — $6.1M
-
First Round
First Round
(30 Apr 2008)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Oct, 2010 | Amount | Series B - Sirigen | Valuation | YFM Equity Partners , IQ Capital | |
| May, 2009 | Amount | Series A - Sirigen | Valuation | Oxford Capital , Seraphim |
|
| Apr, 2008 | Amount | Series A - Sirigen | Valuation | Seraphim , Oxford Capital |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Sirigen
Sirigen has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include BD, Seraphim and YFM Equity Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage space-tech startups are invested in by Seraphim.
|
Founded Year | Domain | Location | |
|
Early-stage venture capital is invested in UK technology sectors.
|
Founded Year | Domain | Location | |
|
Private equity firm focused on multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Sirigen
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Sirigen
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Sirigen Comparisons
Competitors of Sirigen
Sirigen operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NuProbe, Nanosphere, ATDBio, Marker Gene Technologies and DestiNA Genomics, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Sensitive multiplex platforms for QPCR are developed using toehold probes.
|
|
| domain | founded_year | HQ Location |
Diagnostic tests for personalized medicine targeting infections are provided.
|
|
| domain | founded_year | HQ Location |
Developer of oligonucleotides
|
|
| domain | founded_year | HQ Location |
Develops kits and reagents for research application
|
|
| domain | founded_year | HQ Location |
Non-enzymatic nucleic acid detection technology is developed using DGL probes.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Sirigen
Frequently Asked Questions about Sirigen
When was Sirigen founded?
Sirigen was founded in 2003 and raised its 1st funding round 5 years after it was founded.
Where is Sirigen located?
Sirigen is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Sirigen?
Nick Kerton is the current CEO of Sirigen.
Is Sirigen a funded company?
Sirigen is a funded company, having raised a total of $12.05M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3.96M, raised on Apr 30, 2008.
What does Sirigen do?
Sirigen was founded in 2003 in San Diego, United States, within the diagnostics and life sciences sector. High-sensitivity fluorescence detection technologies are created using a platform based on novel polymer chains to improve signal detection in assays. Products are supplied for applications including immunoassays, flow cytometry, proteomics, molecular diagnostics, microarrays, and imaging systems. Operations focus on enhancing traditional assay performance across these areas.
Who are the top competitors of Sirigen?
Sirigen's top competitors include NuProbe, Nanosphere and ATDBio.
Who are Sirigen's investors?
Sirigen has 6 investors. Key investors include BD, Seraphim, YFM Equity Partners, Oxford Capital, and IQ Capital.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.